Advance Intermediate
The products manufactured by TAGOOR LABS are in total compliance with various regulatory requirements and customer expectations, thus enabling us to deliver products of highest quality. All processes and manufacturing operations conform to cGMP requirements, ICH guidelines and regulations, and also compliant with various health authorities like WHO-GMP, NMPA, etc.
| S. No | Product Name | DMF | WHO-GMP |
|---|---|---|---|
| 1 | Domperidone IP/ BP/ Ph. Eur | DMF Available | Available |
| 2 | Desloratadine BP/Ph.Eur/USP | DMF Available | Available |
| 3 | Domperidone Maleate IP/ BP/ Ph. Eur | DMF Available | Available |
| 4 | Esomeprazole Magnesium Tri-Hydrate IP/ Ph. Eur./BP | DMF Available | Available |
| 5 | Favipiravir In-House / IP | DMF Available | Available |
| 6 | Hydroxychloroquine Sulphate IP/Ph. Eur/USP | DMF Available | Available |
| 7 | Loratadine BP/ Ph. Eur /USP | DMF Available | Available |
| 8 | Losartan Potassium IP/BP/ Ph. Eur /USP | DMF Available | Available |
| 9 | Molnupiravir In-House | DMF Available | Available |
| 10 | Omeprazole IP/ BP/ USP/ Ph. Eur | DMF Available | Available |
| 11 | Pantoprazole Sodium Sesquihydrate IP/ Ph. Eur /USP/BP | DMF Available | Available |
| 12 | Terbinafine Hydrochloride IP/ BP/ USP/ Ph. Eur. | DMF Available | Available |
| 13 | Alpha Lipoic acid/Thioctic acid Ph. Eur/ USP/BP | Tech pack Available | Available |
| 14 | Bempedoic acid In-House | Tech pack Available | Available |
| 15 | Cyproheptadine HCl IP/BP/ Ph. Eur /USP | Tech pack Available | Available |
| 16 | Dapagliflozin | Tech pack Available | Available |
| 17 | Dexlansoprazole | Tech pack Available | Available |
| 18 | Empagliflozin | Tech pack Available | Available |
| 19 | Fexofenadine Hydrochloride IP/USP/Ph. Eur/BP | Tech pack Available | Available |
| 20 | Imatinib Mesylate IP/Ph. Eur | Tech pack Available | Available |
| 21 | Itraconazole | Tech pack Available | Available |
| 22 | Lapatanib In-House | Tech pack Available | Available |
| 23 | Levocetrizine | Tech pack Available | Available |
| 24 | Loperamide Hydrochloride IP/BP/ Ph. Eur /USP | Tech pack Available | Available |
| 25 | Rupatadine Fumarate IP | Tech pack Available | Available |
| 26 | Vildagliptin IP/In-House | Tech pack Available | Available |
Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries.
| S. No | Product Name | DMF | WHO-GMP |
|---|---|---|---|
| 1 | Telmisartan | Available | |
| 2 | Fluconazole |
Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries.
| S.No. | NAME OF ADVANCED INTERMEDIATE | RELATED API | CAS NUMBER |
|---|---|---|---|
| 1 | 2-Chloromethyl-3,4-dimethoxypyridine HCl | Pantoprazole | 72830-09-2 |
| 2 | 5-Difluoromethoxy-2-mercapto-1-H-benzimidazole | Pantoprazole | 97963-62-7 |
| 3 | 5-(Difluoro methoxy)-2-{[(3,4 dimethoxypyridin-2-yl)methyl]thio}-1H-benzimidazole (Panto Sulfide) | Pantoprazole | 102625-64-9 |
| 4 | 2-Hydroxymethyl-3,5-dimethyl,4-methoxy pyridine | Omeprazole/Esomeprazole | 86604-78-6 |
| 5 | 2-Chloromethyl-3,5-dimethyl-4-methoxypyridine HCl | Omeprazole/Esomeprazole | 86604-75-3 |
| 6 | 5-Methoxy-2[[(4-methoxy-3,5-dimethyl-2-methylpyridyl]1H-thio benzimidazole (Ome sulfide) | Omeprazole/Esomeprazole | 73590-85-9 |
| 7 | N-Methyl-1-naphthalene methylamine HCl | Terbinafine HCl | 65473-13-4 |
| 8 | N-Methyl-1-naphthalene methylamine (Base) | Terbinafine HCl | 14489-75-9 |
| 9 | 4-(4-Chlorophenyl)-4-hydroxy piperidine | Haloperidol/Loperamide HCl | 39512-49-7 |
| 10 | Dihydro-N,N-dimethyl-3,3-diphenyl-2(3H)-furaniminium bromide | Loperamide | 37743-18-3 |
| 11 | 2-Cyano-3-[2(3-chloro phenyl) ethyl]pyridine (L-5) | Loratadine | 31255-57-9 |
| 12 | 8-Chloro-6,11-dihydro-11-(1-methyl-4-piperidinylidene)-5H-benzo[5,6] cyclohepta[1,2-b]pyridine (N-Merthyl Desloratadine) | Loratadine | 38092-89-6 |
| 13 | 2-N-Butyl-1,3-diazaspiro(4,4)non-1-en-4-one Hydrochloride (Spiro Compound) | Irbesartan | 151257-01-1 |
| 14 | N-(Triphenylmethyl)-5-(4’bromomethyl-biphenyl-2-yl)tetrzole | Losartan potassium, Irbesartan, Valsartan, Olmesartan medoxomil, Fimasartan Potassium Trihydrate | 124750-51-2 |
| 15 | 2-Butyl-4-chloro-5-formylimidazole | Losartan potassium, Eprosartan mesylate | 83857-96-9 |
| 16 | 2-Butyl-4-chloro-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol | Losartan potassium, Allisartan Isoproxil | 114798-26-4 |
| 17 | 6-Fluoro-3-hydroxypyrazine-2-carbonitrile dicyclohexylamine | Favipiravir | 1137606-74-6 |
| 18 | 1-(3-Chloropropyl)-1,3-dihydro-2H-benzimidazol-2-one | Domperidone | 62780-89-6 |
| 19 | 5-Chloro-1-piperidine-4-yl-1,3-dihydro-2H-benzimidazol-2-one | Domperidone | 53786-28-0 |
| 20 | Dibenzosuberone | Amitriptyline HCl/Nortriptyline HCl | 1210-35-1 |
| 21 | Dibenzosuberenone | Cyclobenzaprine HCl/Cyproheptadine HCl, | 2222-33-5 |
| 22 | (S)-1-(2-Chloroacetyl)pyrrolidine-2-carbonitrile | Vildagliptin | 207557-35-5 |
| 23 | (S)-1-(Chloroacetyl)-2-pyrrolidine carboxamide | Vildagliptin | 214398-99-9 |
| 24 | 3-Aminoadamantan-1-ol | Vildagliptin | 702-82-9 |
| 25 | N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine | Imatinib | 152460-10-1 |
| 26 | 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride | Imatinib | 106261-49-8 |
| 27 | 4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide (Imatinib base) | Imatinib | 152459-95-5 |
| 28 | 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride | Sitagliptin | 762240-92-6 |
| 29 | Methyl 2-(4-(4-chlorobutanoyl)phenyl)-2-methylpropanoate | Fexofenadine | 154477-54-0 |
| 30 | alpha,alpha-Diphenyl-4-piperidinomethanol | Fexofenadine | 115-46-8 |
| 31 | Methyl 4-[4-[4-hydroxydiphenylmethyl)-1-piperidinyl] 1-oxobutyl]-2,2-dimethyl benzene acetate | Fexofenadine | 154477-55-1 |
| 32 | 1-(2,3-Dichlorophenyl)Piperazine Hydrochloride (DCPH) | 119532-26-2 | Aripiprazole |
| 33 | 2-(4-(Cyclopropanecarboyl)Phenyl)-2-Methylpropanoic Acid | 162096-54-0 | Fexofenadine |
| 34 | 4,7-dichloroquinoline (4,7-DCQ) | 86-98-6 | Hydroxychloroquine sulfate |
| 35 | 5-(N-Ethyl-N-2-hydroxyethyl amino)-2 -pentylamine (HNDA) | 69559-11-1 | Hydroxychloroquine sulfate |
| 36 | 3-Acetyl pyridine | 350-03-8 | Imatinib |
| 37 | 7,8-Dimethoxy-1,3,4,5-tetrahydrobenzo[d]azepin-2-one | 20925-64-8 | Ivabradine |
| 38 | 7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one | 73942-87-7 | Ivabradine |
| 39 | 2-(Bromomethyl)-3-nitrobenzoic Acid Methyl Ester | 98475-07-1 | Lenalidomide |
| 40 | 3-Aminopiperidine-2,6-dione hydrochloride (3AP) | 24666-56-6 | Lenalidomide |
| 41 | 5-Methylnicotinic acid | 3222-49-9 | Rupatadine |
| 42 | 3-(Chloromethyl)-5-methylpyridine hydrochloride | 1007089-84-0 | Rupatadine |
| 43 | 4-Chloropyrrolo[2,3-d]pyrimidine | 3680-69-1 | Tofacitinib |
| 44 | 2,2,14,14-Tetramethyl-8-oxopentadecanedioic acid diethyl ester | 738606-43-4 | Bempedoic Acid |
| 45 | 2,2,14,14-Tetramethyl-8-oxopentadecanedioic acid | 413624-71-2 | Bempedoic Acid |
| 46 | Isocyano methyl Sulfonyl Methyl benzene | 36635-61-7 | Bempedoic Acid |
| 47 | 4,5-Dimethoxy-1-cyanobenzocyclobutane | 35202-54-1 | Ivabradine HCl |
| 48 | (1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane hydrochloride | 866783-13-3 | Ivabradine HCl |
S.No. | PRODUCT | RELATED API | CAS NUMBER |
|---|---|---|---|
| 1 | N-Methyl-4-piperidone | Loratadine, Ketotifene, Zavegepant & Aclaftadine | 1445-73-4 |
| 2 | N-Methyl-4-hydroxy-piperidine | Domperidone | 106-52-5 |
| 3 | N-Carbethoxy-4-piperidone | Domperidone, Haloperidol | 29976-53-2 |
| 4 | Ethyl 4-hydroxypiperidine-1-carboxylate | Drug Intermediate | 65214-82-6 |
| 5 | 4-Hydroxypiperidine | Bepotastine besylate, Nadifloxacin | 5382-16-1 |
| 6 | N-Methyl-4-chloropiperidine | Domperidone | 5570-77-4 |
7 | 4-Aminopiperidine | Lomitapide, Crenolanib, Relebactam, Gepotidacin, Prucalopride Succinate, Astemizole | 13035-19-3 |
8 | Ethyl 4-aminopiperidine-1-carboxylate | Crizotinib | 58859-46-4 |
9 | 4-Piperidinopiperidine | Irinotecan | 4897-50-1 |
10 | 4-Piperidinylpiperidine dihydrochloride | Irinotecan | 172281-92-4 |
11 | 1-Methylpiperidine-4-amine | Drug Intermediate | 41838-46-4 |
12 | N-BOC-3-Piperidone | Avarofloxacin | 98977-36-7 |
Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries.
The products manufactured by TAGOOR LABS are in total compliance with various regulatory requirements and customer expectations, thus enabling us to deliver products of highest quality. All processes and manufacturing operations conform to cGMP requirements, ICH guidelines and regulations, and also compliant with various health authorities like WHO-GMP, NMPA, etc.
Products List
| Sl No. | NAME OF THE INTERMEDIATE | CAS NUMBER |
|---|---|---|
| Pantoprazole sodium | ||
| 1 | 2-Chloromethyl-3,4-dimethoxypyridine hydrochloride (Panto Chloro) | 72830-09-2 |
| 2 | 5-Difluoromethoxy-2-mercaptobenzimidazole | 97963-62-7 |
| 3 | 5-(Difluoro methoxy)-2-{[(3,4 dimethoxypyridin-2-yl)methyl]thio}-1H-benzimidazole (Panto Sulfide) | 102625-64-9 |
| Omeprazole and Esomeprazole | ||
| 4 | 4-Methoxy-3,5-dimethyl-2-pyridinemethanol (Ome hydroxy base) | 86604-78-6 |
| 5 | 2-(Chloromethyl)-4-methoxy-3,5-dimethylpyridine hydrochloride (Ome Chloro) | 86604-75-3 |
| 6 | 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole (Ome Sulfide) | 73590-85-9 |
| Domperidone | ||
| 7 | 1-(3-Chloropropyl)-1,3-dihydro-2H-benzimidazol-2-one (DOM-II) | 62780-89-6 |
| 8 | 5-Chloro-1-piperidine-4-yl-1,3-dihydro-2H-benzimidazol-2-one (DOM-IX) | 53786-28-0 |
| Lansoprazole and Dexlansoprazole | ||
| 9 | 2-Chloromethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine hydrochloride (Lanso Chloro) | 127337-60-4 |
| 10 | 2-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridylmethylthio]benzimidazole (Lanso Sulfide) | 103577-40-8 |
| Rabeprazole | ||
| 11 | (4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methanol HCl | 675198-19-3 |
| 12 | 2-Chloromethyl-3-methyl-4-(3-methoxypropoxy)pyridine hydrochloride | 153259-31-5 |
| 13 | 2-[[[4-(3-Methoxypropoxy)-3-methylpyridine-2-yl ]methyl]thio]-1H-benzimidazole (Rabeprazole Sulfide) | 117977-21-6 |
| Loratadine, Desloratadine and Rupatadine | ||
| 14 | 2-Cyano-3-(3-chlorophenylethyl)pyridine (L-5) | 31255-57-9 |
| 15 | N-Methyl-4-chloropiperidine | 5570-77-4 |
| 16 | 8-Chloro-6,11-dihydro-11-(1-methyl-4-piperidinylidene)-5H-benzo[5,6] cyclohepta [1,2-b]pyridine (N-Methyl Desloratadine) | 38092-89-6 |
| 17 | 5-Methylnicotinic acid | 3222-49-9 |
| 18 | 3-Chloromethyl-5-methylpyridine hydrochloride | 1007089-84-0 |
| Bilastine | ||
| 19 | 4-(2-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)propan-2-yl)phenethyl 4-methylbenzenesulfonate | 202189-76-2 |
| 20 | 1-(2-Ethoxyethyl)-2-piperidine-4-yl-1H-benzimidazole hydrochloride | 1841081-72-8 |
| 21 | Methyl 2-(4-(2-chloroethyl)phenyl)-2-methylpropanoate | 1181267-33-3 |
| 22 | 2-Ethoxyethyl-4-methylbenzenesulfonate | 17178-11-9 |
| 23 | 2-Piperidin-4-yl-1H-benzoimidazole | 38385-95-4 |
| Cyclobenzaprine HCl and Cyproheptadine HCl | ||
| 24 | Dibenzosuberenone | 2222-33-5 |
| Vildagliptin | ||
| 25 | 3-Aminoadamantan-1-ol | 702-82-9 |
| 26 | (S)-1-(2-Chloroacetyl)pyrrolidine-2-carbonitrile | 207557-35-5 |
| Ivabradine | ||
| 27 | 3-(3-Iodopropyl)-7,8-dimethoxy-1H-benzo[d]azepin-2(3H)-one | 148870-57-9 |
| 28 | 3-(3-Chloropropyl)-1,3-dihydro-7,8-dimethoxy-2H-3-benzazepin-2-one | 85175-59-3 |
| 29 | 7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one | 73942-87-7 |
| 30 | 4,5-Dimethoxy-1-cyanobenzocyclobutane | 35202-54-1 |
| 31 | (1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane hydrochloride | 866783-13-3 |
| Imatinib | ||
| 32 | 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride | 106261-49-8 |
| 33 | 4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide (Imatinib base) | 152459-95-5 |
| 34 | N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine | 152460-10-1 |
| 35 | 3-Acetyl pyridine | 350-03-8 |
| Lenalidomide | ||
| 36 | 2-(Bromomethyl)-3-nitrobenzoic acid methyl ester | 98475-07-1 |
| 37 | 3-Aminopiperidine-2,6-dione hydrochloride (3AP) | 24666-56-6 |
| Cabozantinib | ||
| 38 | 4-Chloro-6,7-dimethoxyquinoline | 35654-56-9 |
| 39 | 1-((4-Fluoro phenyl) carbamoyl) cyclopropane carboxylic acid | 849217-48-7 |
| 40 | 4-((6,7-Dimethoxyquinolin-4-yl)oxy)aniline | 190728-25-7 |
| 41 | Cyclopropane-1,1-dicarboxylic acid methyl ester | 113020-21-6 |
| 42 | 1,1-Cyclopropanedicarboxylic acid | 598-10-7 |
| Hydroxychloroquine sulfate (HCQS) | ||
| 43 | 4,7-Dichloroquinoline (4,7-DCQ) | 86-98-6 |
| 44 | 5-(N-Ethyl-N-2-hydroxyethyl amino)-2 -pentylamine (HNDA) | 69559-11-1 |
| Terbinafine | ||
| 45 | N-Methyl-1-naphthalene methylamine (Base) | 14489-75-9 |
| 46 | N-Methyl-1-naphthalene methylamine HCl | 65473-13-4 |
| Loperamide | ||
| 47 | 4-(4-Chlorophenyl)-4-hydroxy piperidine (PCP) | 39512-49-7 |
| 48 | 4-Bromo-2,2-diphenyl butyric acid | 37742-98-6 |
| 49 | Dihydro-N,N-dimethyl-3,3-diphenyl-2(3H)-furaniminium bromide | 37743-18-3 |
| Aripiprazole | ||
| 50 | 1-(2,3-Dichlorophenyl)piperazine hydrochloride (DCPH) | 119532-26-2 |
| Irbesartan | ||
| 51 | 2-N-Butyl-1,3-diazaspiro(4,4)non-1-en-4-one hydrochloride (Spiro Compound) | 151257-01-1 |
| Irinotecan | ||
| 52 | 4-Piperidinopiperidine | 4897-50-1 |
| 53 | 4-Piperidinylpiperidine dihydrochloride | 4876-60-2 |
| Golvatinib, Brigatinib | ||
| 54 | 1-Methyl-4-(piperidin-4-yl)piperazine | 53617-36-0 |
| Lasmiditan succinate,Sequifenadine,Azatadine, Risperidone,volinanserin, Ancriviroc,Azacyclonol,Iloperidone and Bilastine | ||
| 55 | Isonipecotic acid/4-Piperidinecarboxylic acid | 498-94-2 |
| Azasetron and Olopatadine | Methyl isonipecotate | 2971-79-1 |
| 56 | Methyl isonipecotate | 2971-79-1 |
| Sequifenadine,Terfinadine, Donepezil,Efinaconazole, volinanserin,Bilastine,umeclidinium and avatrombopag | ||
| 57 | Ethyl isonipecotate | 1126-09-6 |
| Zanubrutinib, Volinanserin | ||
| 58 | 1-Boc-piperidine-4-carboxylic acid | 84358-13-4 |
| Amlodipine | ||
| 59 | Phthaloyl Amlodipine | 88150-62-3 |
| 60 | 3-Ethyl 5-methyl 2(2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4dihydropyridine-3,5-dicarboxylate | 88150-42-9 |
| 61 | Ethyl 4-(2-(1,3-dioxoisoindolin-2-yl)ethoxy)-3-oxobutanoate | 88150-75-8 |
| Amitriptyline HCl and Nortriptyline HCl | ||
| 62 | Dibenzosuberone | 1210-35-1 |
| Cyamemazine/Pericyazine | ||
| 63 | 2-Cyano-phenothiazine | 38642-74-9 |
| Vonoprazan | ||
| 64 | 5-(2-Fluorophenyl)-1H-pyrrole-3-carboxaldehyde | 881674-56-2 |
| 65 | Pyridine-3-sulfonyl chloride | 16133-25-8 |
| Duloxetine | ||
| 66 | (S)-N-Methyl-3-hydroxy-3-(2-thienyl)propanamine | 116539-55-0 |
| Resmetirom | ||
| 67 | Ethyl (2-cyano-2-(2-(3,5-dichloro-4-((5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yl)oxy)phenyl)hydrazono) acetyl)carbamate | 920509-33-7 |
| 68 | 3,5-Dichloro-4-((6-chloro-5-isopropylpyridazin-3-yl)oxy)aniline | 920509-27-9 |
| 69 | 3,6-Dichloro-4-isopropylpyridazine | 107228-51-3 |
| 70 | N-Cyanoacetylurethane | 6629-04-5 |
| 71 | 4-Amino-2,6-dichlorophenol | 5930-28-9 |
| Mavacamten | ||
| 72 | 1-Isopropylpyrimidine-2,4,6(1H,3H,5H)-trione | 69998-14-7 |
| 73 | 6-Chloro-3-isopropylpyrimidine-2,4(1H,3H)-dione. | 887581-47-7 |
| Berotralstat | 24964-64-5 | |
| 74 | 3-Cyanobenzaldehyde | 24964-64-5 |
| Alectinib | 1256584-75-4 | |
| 75 | Tert-butyl-6-cyano-2-(2-(4-ethyl-3-iodophenyl)propan-2-yl)-3H-indole-3-carboxylate | 1256584-75-4 |
| 76 | 9-ethyl-8-iodo-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile | 1256584-80-1 |
| 77 | 4-Morpholinopiperidine | 53617-35-9 |
| Granisetron | 50890-83-0 | |
| 78 | 1-Methylindazole-3-carboxylic acid | 50890-83-0 |
| 79 | Endo-3-amine-9-methyl-9-azabicyclo[3,3,1]nonane | 135906-03-5 |
| Ribociclib | 571188-59-5 | |
| 80 | Tert-Butyl4-(6-aminopyridin-3-yl)piperazine-1-carboxylate | 571188-59-5 |
| Osimertinib | 1421372-94-2 | |
| 81 | N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine | 1421372-94-2 |
| 82 | N1-(2-(Dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)benzene-1,2,4-triamine | 1421372-66-8 |
| Orforglipron | 7254-19-5 | |
| 83 | 5-Bromoindole-2-carboxylic acid | 7254-19-5 |
| 84 | 5-Bromo-4-fluoro-1-methyl-1H-indazole | 1784678-61-0 |
| Suzetrigine | 2649470-87-9 | |
| 85 | (2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-carboxylic acid | 2649470-87-9 |
| 86 | 4-Aminopyridine-2-carboxylic Acid | 100047-36-7 |
| 87 | Methyl 4-aminopyridine-2-carboxylate | 1270294-05-7 |
| Tegoprazan | 1270294-05-7 | |
| 88 | (R)-5,7-Difluorochroman-4-ol | 1270294-05-7 |
| 89 | 1-Benzyl-4-hydroxy-N,N,2-trimethyl-1H-benzo[d]imidazole-6-carboxamide | 1640981-20-9 |
| Zastaprazan | 816450-73-4 | |
| 90 | 8-((2,6-Dimethylbenzyl)amino)-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxylic acid | 816450-73-4 |
| 91 | Methyl 8-((2,6-dimethylbenzyl)amino)-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxylate | 248920-23-2 |
| Etoposide | 35901-25-8 | |
| 92 | 1-O-[(Benzyloxy)carbonyl]-2,3-bis-O-(chloacetyl)-4,6-O-[(1R)-ethylidene]-b-D-glucopyranose | 35901-25-8 |
| Tofacitinib | 90213-66-4 | |
| 93 | 2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine | 90213-66-4 |
| 94 | 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine | 3680-69-1 |
| 95 | (3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride | 1062580-52-2 |
| NCE | 1-Boc-3-hydroxypiperidine | 85275-45-2 |
| 96 | 1-Boc-3-hydroxypiperidine | 85275-45-2 |
| 97 | 2,2,6,6-Tetramethylpiperidine | 768-66-1 |
- Testimonials
Trusted by Pharma Leaders
- COLLABORATE WITH TAGOOR LABORATORIES
Partner With Us for Pharmaceutical Development & Manufacturing
Whether you require API development, Advanced Intermediates, KSMs, custom synthesis, analytical R&D or CDMO support, Tagoor Laboratories brings together scientific expertise and pharmaceutical manufacturing capabilities to address complex development requirements.